201 related articles for article (PubMed ID: 31804471)
1. Heterogeneity and dynamics of active Kras-induced dysplastic lineages from mouse corpus stomach.
Min J; Vega PN; Engevik AC; Williams JA; Yang Q; Patterson LM; Simmons AJ; Bliton RJ; Betts JW; Lau KS; Magness ST; Goldenring JR; Choi E
Nat Commun; 2019 Dec; 10(1):5549. PubMed ID: 31804471
[TBL] [Abstract][Full Text] [Related]
2. Expression of Activated Ras in Gastric Chief Cells of Mice Leads to the Full Spectrum of Metaplastic Lineage Transitions.
Choi E; Hendley AM; Bailey JM; Leach SD; Goldenring JR
Gastroenterology; 2016 Apr; 150(4):918-30.e13. PubMed ID: 26677984
[TBL] [Abstract][Full Text] [Related]
3. Trop2 is upregulated in the transition to dysplasia in the metaplastic gastric mucosa.
Riera KM; Jang B; Min J; Roland JT; Yang Q; Fesmire WT; Camilleri-Broet S; Ferri L; Kim WH; Choi E; Goldenring JR
J Pathol; 2020 Jul; 251(3):336-347. PubMed ID: 32432338
[TBL] [Abstract][Full Text] [Related]
4. Dysplastic Stem Cell Plasticity Functions as a Driving Force for Neoplastic Transformation of Precancerous Gastric Mucosa.
Min J; Zhang C; Bliton RJ; Caldwell B; Caplan L; Presentation KS; Park DJ; Kong SH; Lee HS; Washington MK; Kim WH; Lau KS; Magness ST; Lee HJ; Yang HK; Goldenring JR; Choi E
Gastroenterology; 2022 Oct; 163(4):875-890. PubMed ID: 35700772
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of Notch Signaling in Kras-Induced Gastric Metaplasia.
Chung WC; Zhou Y; Atfi A; Xu K
Neoplasia; 2019 Aug; 21(8):810-821. PubMed ID: 31276933
[TBL] [Abstract][Full Text] [Related]
6. Three types of metaplasia model through Kras activation, Pten deletion, or Cdh1 deletion in the gastric epithelium.
Kinoshita H; Hayakawa Y; Konishi M; Hata M; Tsuboi M; Hayata Y; Hikiba Y; Ihara S; Nakagawa H; Ikenoue T; Ushiku T; Fukayama M; Hirata Y; Koike K
J Pathol; 2019 Jan; 247(1):35-47. PubMed ID: 30168144
[TBL] [Abstract][Full Text] [Related]
7. Induction of Gastric Cancer by Successive Oncogenic Activation in the Corpus.
Douchi D; Yamamura A; Matsuo J; Melissa Lim YH; Nuttonmanit N; Shimura M; Suda K; Chen S; Pang S; Kohu K; Abe T; Shioi G; Kim G; Shabbir A; Srivastava S; Unno M; Bok-Yan So J; Teh M; Yeoh KG; Chuang LSH; Ito Y
Gastroenterology; 2021 Dec; 161(6):1907-1923.e26. PubMed ID: 34391772
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic Fatty Acid Metabolism Rewires Energy Supply Chain in Gastric Carcinogenesis.
Won Y; Jang B; Lee SH; Reyzer ML; Presentation KS; Kim H; Caldwell B; Zhang C; Lee HS; Lee C; Trinh VQ; Tan MCB; Kim K; Caprioli RM; Choi E
Gastroenterology; 2024 May; 166(5):772-786.e14. PubMed ID: 38272100
[TBL] [Abstract][Full Text] [Related]
9. Targeting Stem Cells and Dysplastic Features With Dual MEK/ERK and STAT3 Suppression in Gastric Carcinogenesis.
Kim H; Jang B; Zhang C; Caldwell B; Park DJ; Kong SH; Lee HJ; Yang HK; Goldenring JR; Choi E
Gastroenterology; 2024 Jan; 166(1):117-131. PubMed ID: 37802423
[TBL] [Abstract][Full Text] [Related]
10. Identification of Stem Cells in the Epithelium of the Stomach Corpus and Antrum of Mice.
Matsuo J; Kimura S; Yamamura A; Koh CP; Hossain MZ; Heng DL; Kohu K; Voon DC; Hiai H; Unno M; So JB; Zhu F; Srivastava S; Teh M; Yeoh KG; Osato M; Ito Y
Gastroenterology; 2017 Jan; 152(1):218-231.e14. PubMed ID: 27670082
[TBL] [Abstract][Full Text] [Related]
11. Mouse Models of Human Gastric Cancer Subtypes With Stomach-Specific CreERT2-Mediated Pathway Alterations.
Seidlitz T; Chen YT; Uhlemann H; Schölch S; Kochall S; Merker SR; Klimova A; Hennig A; Schweitzer C; Pape K; Baretton GB; Welsch T; Aust DE; Weitz J; Koo BK; Stange DE
Gastroenterology; 2019 Dec; 157(6):1599-1614.e2. PubMed ID: 31585123
[TBL] [Abstract][Full Text] [Related]
12. Mist1 Expressing Gastric Stem Cells Maintain the Normal and Neoplastic Gastric Epithelium and Are Supported by a Perivascular Stem Cell Niche.
Hayakawa Y; Ariyama H; Stancikova J; Sakitani K; Asfaha S; Renz BW; Dubeykovskaya ZA; Shibata W; Wang H; Westphalen CB; Chen X; Takemoto Y; Kim W; Khurana SS; Tailor Y; Nagar K; Tomita H; Hara A; Sepulveda AR; Setlik W; Gershon MD; Saha S; Ding L; Shen Z; Fox JG; Friedman RA; Konieczny SF; Worthley DL; Korinek V; Wang TC
Cancer Cell; 2015 Dec; 28(6):800-814. PubMed ID: 26585400
[TBL] [Abstract][Full Text] [Related]
13. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
[TBL] [Abstract][Full Text] [Related]
14. Loss of Pten and Activation of Kras Synergistically Induce Formation of Intraductal Papillary Mucinous Neoplasia From Pancreatic Ductal Cells in Mice.
Kopp JL; Dubois CL; Schaeffer DF; Samani A; Taghizadeh F; Cowan RW; Rhim AD; Stiles BL; Valasek M; Sander M
Gastroenterology; 2018 Apr; 154(5):1509-1523.e5. PubMed ID: 29273451
[TBL] [Abstract][Full Text] [Related]
15. MEK inhibition suppresses metastatic progression of KRAS-mutated gastric cancer.
Yamasaki J; Hirata Y; Otsuki Y; Suina K; Saito Y; Masuda K; Okazaki S; Ishimoto T; Saya H; Nagano O
Cancer Sci; 2022 Mar; 113(3):916-925. PubMed ID: 34931404
[TBL] [Abstract][Full Text] [Related]
16. Transgenic expression of interferon-γ in mouse stomach leads to inflammation, metaplasia, and dysplasia.
Syu LJ; El-Zaatari M; Eaton KA; Liu Z; Tetarbe M; Keeley TM; Pero J; Ferris J; Wilbert D; Kaatz A; Zheng X; Qiao X; Grachtchouk M; Gumucio DL; Merchant JL; Samuelson LC; Dlugosz AA
Am J Pathol; 2012 Dec; 181(6):2114-25. PubMed ID: 23036899
[TBL] [Abstract][Full Text] [Related]
17. CDKN2A-p16 Deletion and Activated KRAS
Sun J; Sepulveda JL; Komissarova EV; Hills C; Seckar TD; LeFevre NM; Simonyan H; Young C; Su G; Del Portillo A; Wang TC; Sepulveda AR
Cell Mol Gastroenterol Hepatol; 2024; 17(5):769-784. PubMed ID: 38296052
[TBL] [Abstract][Full Text] [Related]
18. KRAS(G12D)- and BRAF(V600E)-induced transformation of murine pancreatic epithelial cells requires MEK/ERK-stimulated IGF1R signaling.
Appleman VA; Ahronian LG; Cai J; Klimstra DS; Lewis BC
Mol Cancer Res; 2012 Sep; 10(9):1228-39. PubMed ID: 22871572
[TBL] [Abstract][Full Text] [Related]
19. Mouse tissues that undergo neoplastic progression after K-Ras activation are distinguished by nuclear translocation of phospho-Erk1/2 and robust tumor suppressor responses.
Parikh N; Shuck RL; Nguyen TA; Herron A; Donehower LA
Mol Cancer Res; 2012 Jun; 10(6):845-55. PubMed ID: 22532587
[TBL] [Abstract][Full Text] [Related]
20. Kras(G12D) induces EGFR-MYC cross signaling in murine primary pancreatic ductal epithelial cells.
Diersch S; Wirth M; Schneeweis C; Jörs S; Geisler F; Siveke JT; Rad R; Schmid RM; Saur D; Rustgi AK; Reichert M; Schneider G
Oncogene; 2016 Jul; 35(29):3880-6. PubMed ID: 26592448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
